Sponsored · This article is produced in paid partnership with GreenMedical. Editorial classification, selection, and evaluation of data remain with Hanf Magazin.
When a telemedicine provider surveys its own patients about what matters most in their care, convenience might seem like the obvious answer. But a survey of 5,556 cannabis patients by GreenMedical tells a different story: data protection, verified quality, and autonomy top the list—not speed or price.
The digital health platform GreenMedical surveyed its patient base in summer 2026 and published the results in a whitepaper. We reviewed the data because it touches on a question we find editorially compelling: what do people undergoing cannabis therapy actually expect from modern, digital healthcare? And what do provider surveys really tell us—and what don’t they?
How the Survey Was Conducted
The survey ran from August 3–10, 2026, using the Typeform survey tool. GreenMedical contacted 125,997 patients; 6,218 started the survey, and 5,556 responses were analyzed. The return rate is not disclosed, and results were not extrapolated to the broader population.
Important context—which GreenMedical itself makes clear: this was a customer survey. The responses reflect the perspective of participating GreenMedical patients and are not representative of all people receiving medical cannabis therapy in Germany. Readers are looking at the view of a specific, digitally served group, not the entire market.
Security Beats Convenience
Respondents rated 15 aspects on a scale from 1 („not important at all“) to 5 („very important“). The results show the percentage selecting the highest level (5). Nine aspects yielded clear data, with a striking order:
- Protection of health data – 84.0%
- Verified quality with guaranteed THC/CBD content – 83.6%
- Control over who knows about your treatment – 83.3%
- Ability to organize treatment online – 77.2%
- Free choice of pharmacy – 71.7%
- Fast medication availability – 66.4%
- Prices matching local pharmacies – 63.4%
- Clinic and lab backing the telemedicine provider – 52.7%
- Support for local pharmacies and doctors – 45.5%
The three highest values cluster tightly between 83.3 and 84.0 percent. What stands out is not the individual figures but the ranking itself: data protection, quality assurance, and control over who learns about your treatment outrank the ability to manage everything online (77.2%), fast availability (66.4%), and price (63.4%). Even among a digitally served population, security and discretion matter more than convenience.
Video Doctor Visits Fall to the Middle
One detail stands out, especially coming from a telemedicine provider: the personal doctor consultation via video achieves only an average score of 2.98 on the 1–5 scale—almost exactly the midpoint. For respondents, video contact is neither particularly important nor unimportant. This fits the broader picture: what matters is not the channel, but that care is secure, verified, and self-directed.
The Three Most Important Aspects in Direct Comparison
In another question, respondents selected their three most important aspects. Since each of the 5,556 responses included three choices, this generated 16,668 total mentions. Of these, 18% referred to health data protection, and roughly 13% (2,146 mentions) to verified quality with guaranteed THC/CBD content.
Precision matters here: these 18% represent a share of all mentions, not a share of individuals. Saying „18% of patients named data protection“ would be incorrect, because the published figures don’t show how many individual persons selected each aspect. GreenMedical makes this distinction clear in its whitepaper, which speaks to the care taken in presenting the data.
What the Data Shows—and What It Doesn’t
Because provider surveys often get reduced to snappy headlines, it’s important to understand their limits. What is demonstrated: among participating GreenMedical patients, data protection, verified quality, and autonomy received the highest approval ratings. What is not demonstrated: information about respondents‘ gender, age, region, diagnosis, or therapy duration—these demographic details aren’t in the published sources. Likewise, the data doesn’t permit a complete ranking beyond the nine measured aspects.
What emerges is a consistent signal: people organizing their cannabis therapy digitally apparently won’t compromise on security. Data protection, transparent quality, and control over their own information matter more to them than speed, price, or the convenience of a video appointment. For a market still in motion following the Cannabis Act and Medical Cannabis Act, this is an illuminating snapshot of patient priorities—nothing more, but nothing less.
We asked GreenMedical to explain how they interpret these results, including the less comfortable ones: Dr. Christoph Viebig on trust in digital cannabis care.
Note: This article provides information about market developments and patient perspectives. It is not a health claim, therapeutic claim, or treatment recommendation. Decisions about medical cannabis therapy are made solely by the treating physician. The figures cited come from a non-representative GreenMedical customer survey (Typeform, August 3–10, 2026, n = 5,556 responses analyzed) and reflect the views of participating patients.
Was ist dir bei der Cannabis-Versorgung am wichtigsten?
Source: GreenMedical Customer Survey „Medical Cannabis 2026“, whitepaper and results overview; conducted via Typeform from August 3–10, 2026, n = 5,556 responses analyzed. Learn more: GreenMedical.
Branchen-Update
News, Analysen und Reportagen — mehrmals im Monat direkt in dein Postfach.
Folge uns
